Testing effectiveness (Phase 2)Study completedNCT00236041
What this trial is testing
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Who this might be right for
CancerBreakthrough Pain
Cephalon 38